Abstract
Introduction In the Cite Soleil (CS) shantytown of Haiti, non-partner sexual violence (NPSV) is widespread, involves multiple assailants who do not use condoms and inflict intentional coital injuries. HIV prevalence in Haiti is 2.2%, CS HIV prevalence is 3.6% shame, guilt, self-blame and societal stigma impede access to HIV testing/treatment in a context of low confidentiality. In that context, NPSV victims often succumb to AIDS. Culturally adapted evidence-based HIV interventions (EBIs) can increase HIV awareness and reduce HIV risk.
Methods Following the ADAPT-ITT model, we used purposive sampling to recruit and interview key stakeholders (age 18 and older) in four focus groups (Victims and health providers, as part of adaptation of an EBI HIV (RESPECT) with an orally administered RAPID HIV antibody test (OraQuick) to increase HIV awareness and testing and to reduce HIV risk for victims of NPSV (N=32, 8/focus group). We also introduced trauma-informed care (TIC) to address the post-assault trauma of NPSV victims. Stakeholders were introduced to RESPECT, participated in RESPECT role plays, interpreted OraQuick HIV screen results after viewing a demonstration of a sample collection, and provided feedback on TIC. ATLAS.ti facilitated thematic content analysis of focus group transcripts.
Results Participants unanimously (100%) reported that RESPECT, OraQuick, and TIC were acceptable, feasible, and useful for increasing HIV awareness, reducing shame, guilt, and trauma, and empowering NPSV victims to reduce the risk of HIV acquisition/transmission in future consensual relationships.
Conclusion Establishing the acceptability, feasibility and effectiveness of RESPECT, OraQuick, and TIC in CS is a crucial first step towards responding to the HIV prevention and trauma needs of NPSV victims.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the University of South Florida HIV Research Group
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University of South Florida Institutional Review Board and by the National Bioethics Committee of Haiti.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
